| Name | Title | Contact Details |
|---|
The Schwartz Group is a Buffalo, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Alere is committed to delivering high performance diagnostics that meet growing global demand for accurate, easy-to-use and cost-effective tests. The Alere i molecular platform, for example, delivers lab-quality results for Influenza A&B in less than 15 minutes.
Novartis Consumer Health is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
As a leading DSO, Heartland Dental provides supported dentists, hygienists, and non-clinical team members with world-class non-clinical administrative support to help them achieve sustainable professional and personal growth. What started from the entrepreneurial spirit of Rick Workman, DMD, with a single dental practice, has evolved into supporting over 2,700 dentists in over 1,700 dental offices across 38 states. Heartland Dental is not your typical Dental Support Organization. Its legacy of being built by a dentist, for dentists along with its doctor-led culture and business model enables supported doctors to be the leaders of their practice, working with their teams to focus on providing great dentistry while Heartland Dental focuses on providing support for the day-to-day non-clinical administrative workflow. You can discover more about Heartland Dental`s Doctor Difference by visiting www.heartland.com. Mission: To support doctors and their teams as they deliver the highest quality dental care and experiences to the communities they serve while providing exceptional careers and creating value for our stakeholders.
Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.